Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
32,99 USD | +3,35 % |
|
+1,20 % | -20,66 % |
14.02. | Moderna meldet weiteren Quartalsverlust | MT |
14.02. | Sektor-Update: Aktien des Gesundheitswesens geben am späten Nachmittag nach | MT |
Moderna, Inc. Gruppe: Beziehungs-Chart
Private Unternehmen, die zur gleichen Gruppe wie MODERNA, INC. gehören
Unternehmen | Geschäftsführender Direktor |
---|---|
ModernaTX, Inc.
![]() ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Stéphane Bancel |

MarketScreener is also available in this country: United States.
Switch edition